Beam Therapeutics Inc. (BEAM) Ownership

$24.59

south_east
-$0.22 (-0.87%)
Day's range
$24.18
Day's range
$25.02

Beam Therapeutics Inc. Major Shareholders & Ownership History

Major Shareholder Name Reporting Date Shares Held Market Value Change in Shares Ownership
FARALLON CAPITAL MANAGEMENT LLC 11/14/2024 8.21 M $201.10 M   3.73% 9.96%
VANGUARD GROUP INC 11/13/2024 7.84 M $192.19 M   -0.71% 9.52%
BLACKROCK FUNDING, INC. /DE 11/13/2024 7.75 M $189.83 M   100.00% 9.40%
ARK INVESTMENT MANAGEMENT LLC 10/31/2024 6.53 M $160.01 M   -14.36% 7.93%
ARCH VENTURE MANAGEMENT, LLC 11/14/2024 4.83 M $118.45 M   -11.18% 5.87%
FMR LLC 11/13/2024 4.21 M $103.18 M   -4.45% 5.11%
STATE STREET CORP 11/14/2024 3.93 M $96.27 M   12.53% 4.77%
SUMITOMO MITSUI TRUST HOLDINGS, INC. 11/05/2024 3.55 M $87.04 M   59.72% 4.31%
NIKKO ASSET MANAGEMENT AMERICAS, INC. 11/07/2024 3.55 M $87.04 M   59.72% 4.31%
MWG MANAGEMENT LTD. 11/08/2024 2.27 M $55.54 M   0.00% 2.75%
TEMASEK HOLDINGS (PRIVATE) LTD 11/14/2024 1.81 M $44.42 M   0.00% 2.20%
GEODE CAPITAL MANAGEMENT, LLC 11/12/2024 1.81 M $44.30 M   4.52% 2.19%
REDMILE GROUP, LLC 11/14/2024 1.61 M $39.47 M   -5.40% 1.95%
BELLEVUE GROUP AG 11/14/2024 1.52 M $37.19 M   7.05% 1.84%
CITADEL ADVISORS LLC 11/14/2024 1.50 M $36.66 M   94.52% 1.82%
PRICE T ROWE ASSOCIATES INC /MD/ 11/14/2024 1.49 M $36.42 M   6.65% 1.80%
KYNAM CAPITAL MANAGEMENT, LP 11/14/2024 1.30 M $31.90 M   100.00% 1.58%
DIMENSIONAL FUND ADVISORS LP 11/07/2024 1.24 M $30.39 M   18.20% 1.51%
MORGAN STANLEY 11/14/2024 1.21 M $29.59 M   50.25% 1.47%
CASDIN CAPITAL, LLC 11/14/2024 775,000 $18.99 M   14.81% 0.94%
YIHENG CAPITAL MANAGEMENT, L.P. 11/12/2024 763,760 $18.71 M   -9.67% 0.93%
GOLDMAN SACHS GROUP INC 11/14/2024 680,848 $16.68 M   -13.22% 0.83%
JPMORGAN CHASE & CO 12/26/2024 639,238 $15.66 M   -7.37% 0.78%
CHARLES SCHWAB INVESTMENT MANAGEMENT INC 11/12/2024 629,492 $15.42 M   6.11% 0.76%
BANK OF AMERICA CORP /DE/ 11/14/2024 539,987 $13.23 M   49.11% 0.66%
LOGOS GLOBAL MANAGEMENT LP 11/14/2024 500,000 $12.25 M   100.00% 0.61%
VOLORIDGE INVESTMENT MANAGEMENT, LLC 11/14/2024 463,662 $11.36 M   21.06% 0.56%
BAILLIE GIFFORD & CO 11/05/2024 357,698 $8.76 M   -42.64% 0.43%
ALPHABET INC. 11/08/2024 321,604 $7.88 M   0.00% 0.39%
ROCK SPRINGS CAPITAL MANAGEMENT LP 11/14/2024 249,923 $6.12 M   0.00% 0.30%
BANK OF NEW YORK MELLON CORP 11/12/2024 227,545 $5.57 M   -20.87% 0.28%
SUSQUEHANNA INTERNATIONAL GROUP, LLP 11/14/2024 224,600 $5.50 M   143.07% 0.27%
UBS GROUP AG 11/14/2024 189,194 $4.64 M   16.37% 0.23%
JANE STREET GROUP, LLC 11/15/2024 188,091 $4.61 M   -58.22% 0.23%
RUSSELL INVESTMENTS GROUP, LTD. 11/13/2024 187,845 $4.60 M   10.78% 0.23%
RAFFERTY ASSET MANAGEMENT, LLC 11/13/2024 187,091 $4.58 M   13.21% 0.23%
NUVEEN ASSET MANAGEMENT, LLC 11/14/2024 184,596 $4.52 M   0.00% 0.22%
TD ASSET MANAGEMENT INC 11/01/2024 184,306 $4.62 M   4.78% 0.22%
BARCLAYS PLC 11/19/2024 183,214 $4.49 M   123.90% 0.22%
TANG CAPITAL MANAGEMENT LLC 11/14/2024 170,000 $4.17 M   -37.04% 0.21%
MIRAE ASSET GLOBAL ETFS HOLDINGS LTD. 11/14/2024 156,279 $3.83 M   -10.28% 0.19%
MANUFACTURERS LIFE INSURANCE COMPANY, THE 11/13/2024 145,851 $3.57 M   6.39% 0.18%
SWISS NATIONAL BANK 11/07/2024 136,700 $3.35 M   0.00% 0.17%
VESTMARK ADVISORY SOLUTIONS, INC. 11/14/2024 133,902 $3.28 M   60.21% 0.16%
WALLEYE CAPITAL LLC 11/14/2024 127,588 $3.13 M   21.60% 0.15%
RHUMBLINE ADVISERS 11/12/2024 127,105 $3.11 M   -4.12% 0.15%
SUSQUEHANNA PORTFOLIO STRATEGIES, LLC 11/14/2024 126,710 $3.10 B   -12.34% 0.15%
AMERICAN CENTURY COMPANIES INC 11/12/2024 119,606 $2.93 M   25.14% 0.15%
HUDSON BAY CAPITAL MANAGEMENT LP 11/13/2024 115,000 $2.82 M   206.67% 0.14%
SUSQUEHANNA INTERNATIONAL GROUP, LLP 11/14/2024 112,700 $2.76 M   1.44% 0.14%

Beam Therapeutics Inc.institutional Ownership - FAQ's

Who are the largest shareholders of BEAM shares?

During the previous two years, 255 institutional investors and hedge funds held shares of Beam Therapeutics Inc.. The most heavily invested institutionals were:

FARALLON CAPITAL MANAGEMENT LLC: 8.21 M

VANGUARD GROUP INC: 7.84 M

BlackRock Funding, Inc. /DE: 7.75 M

ARK Investment Management LLC: 6.53 M

ARCH Venture Management, LLC: 4.83 M

FMR LLC: 4.21 M

What percentage of Beam Therapeutics Inc. stock is owned by institutional investors?

95.85% of Beam Therapeutics Inc. stock is owned by institutional investors.

How much institutional buying is happening at BEAM ?

Institutional investors have bought a total of 86.96 M shares in the last 24 months. This purchase volume represents approximately $2.14 B in transactions.